These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1641821)

  • 21. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency.
    Peyvandi F
    Thromb Res; 2009 Dec; 124 Suppl 2():S9-11. PubMed ID: 20109654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New observations on factor XI deficiency.
    Salomon O; Seligsohn U
    Haemophilia; 2004 Oct; 10 Suppl 4():184-7. PubMed ID: 15479396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective survey on the safety of Replenate, a high-purity factor VIII concentrate.
    Gascoigne EW; Dash CH; Harman C; Wilmot D
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):243-52. PubMed ID: 15255091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
    Mintz PD; Neff A; MacKenzie M; Goodnough LT; Hillyer C; Kessler C; McCrae K; Menitove JE; Skikne BS; Damon L; Lopez-Plaza I; Rouault C; Crookston KP; Benjamin RJ; George J; Lin JS; Corash L; Conlan MG
    Transfusion; 2006 Oct; 46(10):1693-704. PubMed ID: 17002625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
    Shortt J; Dunkley S; Rickard K; Baker R; Street A
    Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of factor XI deficiency in gynecologic and obstetric patients.
    Steinberg MH; Saletan S; Funt M; Baker D; Coller BS
    Obstet Gynecol; 1986 Jul; 68(1):130-3. PubMed ID: 3487757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia A.
    Wolf DM; Rokicka-Milewska R; Lopaciuk S; Skotnicki AB; Klukowska A; Laguna P; Windyga J; Kotitschke R; Struff WG
    Haemophilia; 2004 Sep; 10(5):438-48. PubMed ID: 15357768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor XI-related thrombosis and the role of concentrate treatment in factor XI deficiency.
    Pike GN; Bolton-Maggs PH
    Haemophilia; 2015 Jul; 21(4):477-80. PubMed ID: 25855096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Familial study of factor XI deficiency. Presurgical prophylactic treatment with desmopressin plus antifibrinolytics].
    García Fernández JR; Sánchez Forte M; Diego Fernández Pd; López Berenguel F; Moreno Madrid F
    An Esp Pediatr; 2002 Oct; 57(4):373-7. PubMed ID: 12392675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The obstetric experience of women with factor XI deficiency.
    Chi C; Kulkarni A; Lee CA; Kadir RA
    Acta Obstet Gynecol Scand; 2009; 88(10):1095-100. PubMed ID: 19685354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
    de Alarcon P; Benjamin R; Dugdale M; Kessler C; Shopnick R; Smith P; Abshire T; Hambleton J; Matthew P; Ortiz I; Cohen A; Konkle BA; Streiff M; Lee M; Wages D; Corash L
    Transfusion; 2005 Aug; 45(8):1362-72. PubMed ID: 16078927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of factor XI deficiency.
    Bolton-Maggs PH
    Haemophilia; 1998 Jul; 4(4):683-8. PubMed ID: 9873814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of cardiac surgical bleeding with the combination of 4-factor prothrombin complex concentrate and fresh frozen plasma following lack of response to fresh frozen plasma alone in a patient with severe factor XI deficiency.
    Boateng P; Varma M; Chen L; Kyaw H; Kyaw NL; Yoe J
    Blood Coagul Fibrinolysis; 2023 Jul; 34(5):333-336. PubMed ID: 37395189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factor XI deficiency].
    Conde P; Alegria A; Moniz A
    Acta Med Port; 2007; 20(4):375-80. PubMed ID: 18198083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FXI concentrate use and risk of thrombosis.
    Bolton-Maggs P; Goudemand J; Hermans C; Makris M; de Moerloose P
    Haemophilia; 2014 Jul; 20(4):e349-51. PubMed ID: 24785157
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiency.
    Evans G; Pasi KJ; Mehta A; Lee CA; Perry DJ
    Blood Coagul Fibrinolysis; 1997 Oct; 8(7):437-40. PubMed ID: 9391725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XI kinetics after plasma exchange in severe factor XI deficiency.
    Nováková IR; van Ginneken CA; Verbruggen HW; Haanen C
    Haemostasis; 1986; 16(1):51-6. PubMed ID: 3699586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.